GB0425530D0 - Pharmaceutically active compounds - Google Patents

Pharmaceutically active compounds

Info

Publication number
GB0425530D0
GB0425530D0 GB0425530A GB0425530A GB0425530D0 GB 0425530 D0 GB0425530 D0 GB 0425530D0 GB 0425530 A GB0425530 A GB 0425530A GB 0425530 A GB0425530 A GB 0425530A GB 0425530 D0 GB0425530 D0 GB 0425530D0
Authority
GB
United Kingdom
Prior art keywords
active compounds
pharmaceutically active
pharmaceutically
compounds
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0425530A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GBGB0402492.3A priority Critical patent/GB0402492D0/en
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GB0425530A priority patent/GB0425530D0/en
Publication of GB0425530D0 publication Critical patent/GB0425530D0/en
Priority to JP2006551945A priority patent/JP4031814B2/en
Priority to CA2555800A priority patent/CA2555800C/en
Priority to AP2006003699A priority patent/AP2006003699A0/en
Priority to AU2005213538A priority patent/AU2005213538A1/en
Priority to AT05702363T priority patent/ATE511507T1/en
Priority to EP05702363A priority patent/EP1716135B1/en
Priority to KR1020067015811A priority patent/KR100830763B1/en
Priority to CNA2005800075736A priority patent/CN1930146A/en
Priority to EA200601279A priority patent/EA011159B1/en
Priority to PCT/IB2005/000208 priority patent/WO2005077935A1/en
Priority to BRPI0507435-5A priority patent/BRPI0507435A/en
Priority to GEAP20059564A priority patent/GEP20084361B/en
Priority to PE2005000122A priority patent/PE20050772A1/en
Priority to ARP050100409A priority patent/AR048232A1/en
Priority to TW094103372A priority patent/TWI300066B/en
Priority to US11/051,144 priority patent/US7649002B2/en
Priority to UY28737A priority patent/UY28737A1/en
Priority to NL1028193A priority patent/NL1028193C2/en
Priority to PA20058623101A priority patent/PA8623101A1/en
Priority to IL177004A priority patent/IL177004A0/en
Priority to ZA200606236A priority patent/ZA200606236B/en
Priority to EC2006006751A priority patent/ECSP066751A/en
Priority to CR8545A priority patent/CR8545A/en
Priority to MA29242A priority patent/MA28348A1/en
Priority to NO20063944A priority patent/NO20063944L/en
Ceased legal-status Critical Current

Links

GB0425530A 2004-02-04 2004-11-19 Pharmaceutically active compounds Ceased GB0425530D0 (en)

Priority Applications (27)

Application Number Priority Date Filing Date Title
GBGB0402492.3A GB0402492D0 (en) 2004-02-04 2004-02-04 Pharmaceutically active compounds
GB0425530A GB0425530D0 (en) 2004-11-19 2004-11-19 Pharmaceutically active compounds
GEAP20059564A GEP20084361B (en) 2004-02-04 2005-01-26 Piperidinylcarbonyl-pyrro-lidines and their use as melanocortin agonists
BRPI0507435-5A BRPI0507435A (en) 2004-02-04 2005-01-26 piperidinylcarbonylpyrrolidines compounds, processes for their preparation, pharmaceutical composition and use as melanocortin agonists
CA2555800A CA2555800C (en) 2004-02-04 2005-01-26 Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists
AP2006003699A AP2006003699A0 (en) 2004-02-04 2005-01-26 Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists
AU2005213538A AU2005213538A1 (en) 2004-02-04 2005-01-26 Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists
AT05702363T ATE511507T1 (en) 2004-02-04 2005-01-26 PIPERIDINYLCARBONYLPYRROLIDINE AND THEIR USE AS MELANOCORTINAGONISTS
EP05702363A EP1716135B1 (en) 2004-02-04 2005-01-26 Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists
KR1020067015811A KR100830763B1 (en) 2004-02-04 2005-01-26 Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists
CNA2005800075736A CN1930146A (en) 2004-02-04 2005-01-26 Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists
EA200601279A EA011159B1 (en) 2004-02-04 2005-01-26 Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists
PCT/IB2005/000208 WO2005077935A1 (en) 2004-02-04 2005-01-26 Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists
JP2006551945A JP4031814B2 (en) 2004-02-04 2005-01-26 Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists
PE2005000122A PE20050772A1 (en) 2004-02-04 2005-02-02 PIPERIDINYLCARBONYL-PYRROLIDINES AS MELANOCORTINE AGONISTS
UY28737A UY28737A1 (en) 2004-02-04 2005-02-03 PHARMACEUTICALLY ACTIVE COMPOUNDS
ARP050100409A AR048232A1 (en) 2004-02-04 2005-02-03 PIPERIDINILCARBONIL- PIRROLIDINAS AND ITS USE AS AGELISTS OF MELANOCORTINA CR4
TW094103372A TWI300066B (en) 2004-02-04 2005-02-03 Pharmaceutically active compounds
US11/051,144 US7649002B2 (en) 2004-02-04 2005-02-03 (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
NL1028193A NL1028193C2 (en) 2004-02-04 2005-02-04 Pharmaceutically active compounds.
PA20058623101A PA8623101A1 (en) 2004-02-04 2005-02-04 PHARMACEUTICALLY ACTIVE COMPOUNDS
IL177004A IL177004A0 (en) 2004-02-04 2006-07-20 Piperidinylcarbonyl- pyrrolidines and their use as melanocortin agonists
ZA200606236A ZA200606236B (en) 2004-02-04 2006-07-27 Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists
EC2006006751A ECSP066751A (en) 2004-02-04 2006-08-03 PIPERIDINILCARBONIL-PIRROLIDINAS AND ITS USE AS MELANOCORTINE AGONISTS
CR8545A CR8545A (en) 2004-02-04 2006-08-03 PIPERIDINILCARBONIL-PIRROLIDINAS AND ITS EMPLOYMENT AS MELANOCORTIN ASAGONISTS
MA29242A MA28348A1 (en) 2004-02-04 2006-08-04 Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists
NO20063944A NO20063944L (en) 2004-02-04 2006-09-04 Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0425530A GB0425530D0 (en) 2004-11-19 2004-11-19 Pharmaceutically active compounds

Publications (1)

Publication Number Publication Date
GB0425530D0 true GB0425530D0 (en) 2004-12-22

Family

ID=33548565

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0425530A Ceased GB0425530D0 (en) 2004-02-04 2004-11-19 Pharmaceutically active compounds

Country Status (1)

Country Link
GB (1) GB0425530D0 (en)

Similar Documents

Publication Publication Date Title
ZA200703312B (en) Pharmaceutical compounds
GB0423554D0 (en) Therapeutic compounds
NL1028193A1 (en) Pharmaceutically active compounds.
IL181229A0 (en) Noncardiotoxic pharmaceutical compounds
GB0420424D0 (en) Therapeutic compounds
IL180487A0 (en) Medicament
GB0412417D0 (en) Pharmaceutically active compounds
GB0412414D0 (en) Pharmaceutically active compounds
GB0425530D0 (en) Pharmaceutically active compounds
GB0428554D0 (en) Pharmaceutical compounds
GB0424742D0 (en) Pharmaceutical compounds
GB0427138D0 (en) Therapeutic compounds
GB0219897D0 (en) Pharmaceutically active compounds
GB0423767D0 (en) Therapeutic compounds
GB0417560D0 (en) Therapeutic compounds
GB0219893D0 (en) Pharmaceutically active compounds
GB0426942D0 (en) Medicament
GB0409098D0 (en) Medicament
GB0219895D0 (en) Pharmaceutically active compounds
GB0408878D0 (en) Medicinal compounds
GB0411383D0 (en) Pharmaceutical compounds
GB0423655D0 (en) Pharmaceutical compounds
GB0408239D0 (en) Pharmaceutical compounds
GB0412894D0 (en) Pharmaceutical compounds
GB0415082D0 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)